Airtel Allies With Verizon to Offer Video Calling in India - India’s No. 2 mobile phone carrier is allying with Verizon Communications to offer group video calling, a service that’s booming as the pandemic has made face-to-face meetings too risky for many. Bharti Airtel will provide Verizon’s Blue Jeans platform in India. Market Cap is in crs. #MOMarketUpdates#Airtel#MotilalOswal#Nifty50#NSE#BSE#IndianStockMarket#Investing
Posted On:14 Jul 2020 6:02 PM
1) CEO Sundar Pichai announced a $10b Google for India Digitization Fund to help accelerate India's digital economy, according to a company announcement. Google will invest in India over the next 5 to 7 years. 2) Yes Bank the FPO as the floor price has been set at ₹12, almost 50% lower than the market price. The stock has fallen nearly 17% from its Thursday closing. Yes Bank aims to raise fresh capital of ₹15,000 crores through the further purchase offer (FPO). Out of this, ₹200 crores worth of equity shares will be reserved for its employees. A minimum bid of 1,000 equity shares will be allowed and in multiples of 1,000 equity shares after that. 3) Reliance Industries on Monday became the first Indian company to reach a market capitalisation of above Rs12 trillion as its shares doubled since mid-March. The company will also hold its annual general meeting (AGM) this week (15th July). 4) Biocon announced that its "breakthrough drug," Itolizumab received Drugs Controller General of India's approval for its use in moderate to severe Covid-19 patients. 5) Morgan Stanley has reached a deal to lease up to 1.1 million square feet of office space for 9.5 years from Oberoi Realty. The campus will be located in Goregaon, at the company's Commerz III building and will be ready in 2023. #MOMarketUpdates#Google#YesBank#Reliance#Biocon#MorganStanley#indianstockmarket#equity#stocks#NSE#Nifty50#BSE#MotilalOswal
Glenmark Pharmaceuticals shares surged 27% in today’s trade. The company has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate Covid-19 infection at a price of about Rs 103 per tablet....